We are pleased to announce the appointment of Dr. Nell Smircina as President of CuraMedix, ushering in an exciting new chapter in our company’s evolution and growth.
As we look to the future, we have an ambitious vision: to accelerate growth, expand our impact across the healthcare landscape, and strengthen our position as a trusted partner to the providers, health systems, and patients we serve. Under Nell’s leadership, we will build on our strong foundation while pursuing new opportunities for innovation, operational excellence, and sustainable, long-term success.
Our aspirations extend beyond growth alone. We are committed to advancing evidence-based, value-based care by delivering solutions that are clinically meaningful, economically responsible, and focused on improving outcomes. We believe that the future of healthcare depends on the ability to demonstrate measurable value—improving quality, supporting better clinical decisions, enhancing efficiency, and ultimately making a meaningful difference in patients’ lives.
Equally important is our commitment to the experiences we create for our clients and the patients they serve. We will continue to listen, collaborate, and innovate to make every interaction more seamless, responsive, and impactful. By placing clients and patients at the center of our decisions, we can build stronger partnerships, earn lasting trust, and deliver value that extends well beyond our products and services.
Nell brings industry leadership experience, business expertise, in addition to clinical and practice management accomplishments to this role, along with a strong commitment to our mission and the opportunities ahead. We are confident that this leadership will help us align our people, capabilities, and strategy around a shared purpose and a clear path forward.
Our next chapter is about thinking bigger, executing with purpose, and delivering measurable impact. We will set ambitious goals, challenge conventional approaches, invest in our people and capabilities, and hold ourselves accountable for results. By combining disciplined growth with an unwavering focus on clinical evidence, value, and the human experience, we will build a stronger company and contribute to a better healthcare future.
Please join us in welcoming Nell as we embark on this exciting next chapter together.